Market Research Report
Orthopedic Biomaterials Market Report Suite | Australia | 2020-2026 | Medsuite
|Published by||iData Research Inc.||Product code||925593|
|Published||Content info||285 Pages
Delivery time: 1-2 business days
|Orthopedic Biomaterials Market Report Suite | Australia | 2020-2026 | Medsuite|
|Published: February 7, 2020||Content info: 285 Pages||
The Australian orthopedic biomaterials market was valued at $63.8 million in 2019. This is expected to increase over the forecast period at a CAGR of 4.9% to reach $89.4 million.
With some exceptions, tissue supply for allografts and DBM allografts is constrained by the number of available donors. Furthermore, allografts are primarily sold by bone banks in Australia, which is attributed to a relatively high barrier to entry to the market for international companies. As the population ages, there will be a lower supply of eligible bone graft donors.
Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, over 15% of Australians were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.
Single-injection HA viscosupplementation products are relatively new to the Australian market. Although three-injection products were available in Australia before single-injection products, the benefits of the latter are typically perceived to outweigh the favorable cost of the former. As a result, single-injection products are expected to continue to cannibalize three-injection products over the forecast period.
The full report suite on the Australian market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrix (DBM) allografts and synthetics. This report also includes orthopedic growth factors and hyaluronic acid (HA) viscosupplementation.